mechanism differential control nmda receptor activity nr2 subunits
n-methyl-d-aspartate nmda receptors nmdars major class excitatory neurotransmitter receptors central nervous system form glutamate-gated ion channels highly permeable calcium mediate activity-dependent synaptic plasticity nmdar dysfunction implicated multiple brain disorders including stroke chronic pain schizophrenia nmdars exist multiple subtypes distinct pharmacological biophysical properties largely determined type nr2 subunit nr2a nr2d incorporated heteromeric nr1/nr2 complex fundamental difference nmdar subtypes channel maximal open probability po spans fold range nr2a-containing receptors receptors containing nr2c nr2d nr2b-containing receptors intermediate value - differences po confer unique charge transfer capacities signalling properties receptor subtype molecular basis profound difference activity nmdar subtypes unknown show subunit-specific gating nmdars controlled region formed nr2 amino-terminal domain ntd extracellular clamshell-like domain previously shown bind allosteric inhibitors- short linker connecting ntd agonist-binding domain abd subtype specificity nmdar po largely reflects differences spontaneous ligand-independent equilibrium open-cleft closed-cleft conformations nr2-ntd ntd-driven gating control also affects pharmacological properties setting sensitivity endogenous inhibitors zinc protons results provide proof concept drug-based bidirectional control nmdar activity using molecules acting either nr2-ntd closers openers promoting receptor inhibition potentiation respectively
